Neural Therapy in Cesareans

Haseki Training and Research Hospital

Status: Not yet enrolling

Conditions: Visual Analogue Scale

Treatments: Drug: neural therapy

Study type: Observational

Funder types: Other

Identifiers

NCT06999200

NT-2016

Details and patient eligibility

About

In the management of pain after Caesarean section (C/S), opioid or nonsteroidal anti-inflammatory parenteral drugs are applied. These drugs are insufficient in some cases and may cause pain attacks during the day. Higher doses and repeated drug applications or combined drug administration may cause drug side effects and interactions. Alternative applications to provide analgesia include subcutaneous and intracutaneous local anesthetic application to the wound site. Although the effectiveness of these applications has been tested in individuals with different clinical characteristics and has been shown to be largely more successful, they have not been sufficiently introduced into routine practice. There is a need to review the pain methods suggested in the literature and develop new solutions that can be applied more optimally, improve the patient's pain management in the postoperative period, and increase their quality of life and satisfaction.

It aims to evaluate the success of subcutaneous and intracutaneous local anesthesia applications compared to traditional applications, and to find the most optimal management.

Enrollment: 156 estimated patients

Sex: Female

Ages: 19 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Healthy pregnancy,
• Term (>37 weeks) and preterm (28-34 weeks) pregnancy,
• Cases that received general anesthesia for cesarean section,
• Cases with and without labor,
• Cases with and without obesity,
• Cases that had their first or second cesarean section

Exclusion criteria

• Pregnant women under 19 years of age,
• Those with a history of allergic reactions to analgesics to be used,
• Stillbirth,
• Surgical complications during C/S and placement of an abdominal drain,
• No head or breech presentation during C/S,
• Occiput posterior presentation during C/S,
• Anhydramnios and polyhydramnios,
• Allergic reactions to the drugs used in the study, alcohol dependence, drug and substance dependence, chronic pain syndrome, neuropathic pain disorder history,
• History of clinically significant cardiovascular, pulmonary, hepatic, renal, neurological, psychiatric, metabolic disease.

Trial design

156 participants in 3 patient groups

Subcutaneous local anesthesia group

Description:

who received subcutaneous local anesthesia at the end of C/S surgery

Treatment:

Drug: neural therapy

Intracutaneous local anesthesia group

Description:

who received intracutaneous local anesthesia at the end of C/S surgery

Treatment:

Drug: neural therapy

Parenteral analgesia group

Description:

who received parenteral analgesia after C/S surgery

Treatment:

Drug: neural therapy